Zacks Investment ResearchMon, 06 Apr 2026 14:15:29 GMTRelay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?RLAY+4.03%
The Motley FoolThu, 19 Mar 2026 19:03:04 GMTIs Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.RLAY+4.03%
Seeking AlphaWed, 11 Mar 2026 16:42:22 GMTRelay Therapeutics, Inc. (RLAY) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptRLAY+4.03%
Zacks Investment ResearchWed, 11 Mar 2026 14:06:09 GMTRelay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?RLAY+4.03%
Seeking AlphaFri, 06 Mar 2026 20:45:57 GMTRelay Therapeutics, Inc. (RLAY) Presents at TD Cowen 46th Annual Health Care Conference TranscriptRLAY+4.03%
Seeking AlphaThu, 05 Mar 2026 10:42:11 GMTRelay Therapeutics: Breakthrough Designation Sets The Stage For A Key Zovegalisib Data CatalystRLAY+4.03%
The Motley FoolFri, 27 Feb 2026 15:58:28 GMTRelay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 MillionRLAY+4.03%
Zacks Investment ResearchFri, 27 Feb 2026 00:01:14 GMTRelay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue EstimatesRLAY+4.03%
The Motley FoolFri, 06 Feb 2026 19:56:01 GMTRelay Therapeutics Insider Sells 21,000 Shares for $166,700 After 65% RunRLAY+4.03%
Seeking AlphaWed, 28 Jan 2026 11:38:24 GMTOppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib OptimismRLAY+4.03%
